Last reviewed · How we verify
Placebo enteric-coated tablet — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo enteric-coated tablet (Placebo enteric-coated tablet) — POLYSAN Scientific & Technological Pharmaceutical Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo enteric-coated tablet TARGET | Placebo enteric-coated tablet | POLYSAN Scientific & Technological Pharmaceutical Company | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo enteric-coated tablet CI watch — RSS
- Placebo enteric-coated tablet CI watch — Atom
- Placebo enteric-coated tablet CI watch — JSON
- Placebo enteric-coated tablet alone — RSS
Cite this brief
Drug Landscape (2026). Placebo enteric-coated tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-enteric-coated-tablet. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing